As the pharmaceutical industry battles with regulators over the extent to which clinical trial information should be released, one drug maker has run afoul of U.K. industry rules for disclosure.
The Association of British Pharmaceutical Industry has ruled that Servier breached several codes by failing to publish trial results for its Valdoxan antidepressant. Specifically, there were five trials involving U.K. patients between 2008 and 2011 in which Servier did not publish results promptly and three other trials in which results had not been disclosed.
Help employers find you! Check out all the jobs and post your resume.
